NCT00207714View on ClinicalTrials.gov

An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2006

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Golimumab

Type=exact, unit=mg/ml, number= 50 to 100 , form=powder for solution for infusion, route=sub cutaneous.

DRUG

MTX

Type=exact, unit=mg/ml, number= 10, form=powder for solution for infusion, route=sub cutaneous

DRUG

Placebo

Type=exact, unit=mg/ml, form=powder for solution for infusion, route=sub cutaneous

DRUG

Infliximab

Type=exact, unit=mg/ml number= 10, form=powder for solution for infusion, route=sub cutaneous

Sponsors

Lead Sponsor

Centocor, Inc.

Collaborators (1)

Centocor BV
All Listed Sponsors
collaborator

Centocor BV

INDUSTRY

lead

Centocor, Inc.

INDUSTRY